Three (3) Rigaku Icon-X Handheld 1064nm Raman Spectrometers - Brand Name
Closed Solicitation Posted
- Solicitation number
- OC-OCS-26-C-4920
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Cincinnati, Ohio 45237, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration seeks quotations for three Rigaku Icon-X handheld 1064nm Raman spectrometers with CommandSuite software, familiarization training for up to six users per instrument, and a three-year manufacturer's warranty, with quotations due July 29 and questions due July 24. This is a brand-name procurement with no "or equal" products permitted.
Place of performance is Cincinnati, OH 45237, with delivery F.O.B. Destination required no later than ninety days after award. The procurement is unrestricted as to source and business size (NAICS 334516, small business standard 1,000 employees; PSC 6640). Quotations are accepted from the OEM or from dealers and resellers currently authorized by Rigaku Analytical Devices; all quoters other than the OEM must submit evidence of current authorization. Used, refurbished, demonstration, or gray-market equipment will not be considered.
The Brand-Name Justification cites mandatory salient characteristics that only the Rigaku Icon-X meets: 1064nm laser wavelength to suppress fluorescence on dark, colored, or mixed samples; 490mW maximum laser power exceeding competing products; 6–13cm-1 spectral resolution superior to alternatives; and interoperability with NFCC's established Rigaku workflow without requiring user calibration. Fourteen competing handheld Raman instruments were evaluated and all failed one or more mandatory requirements or were end-of-life.
Award will be made under FAR Part 13 Simplified Acquisition Procedures as a single firm-fixed-price purchase order to the responsible quoter with the lowest-priced, technically acceptable quotation. Pricing must be valid for a minimum of sixty days. Quoters must be SAM.gov-registered with active UEI and must confirm delivery timeline, warranty terms, and completed telecommunications equipment representations.
Notice text
This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice and the attached documents. This announcement constitutes the only solicitation; quotations are being requested, and a separate written solicitation will not be issued. Solicitation number OC-OCS-26-C4920 is issued as a Request for Quotations (RFQ). The incorporated provisions and clauses are those in effect through the most current Federal Acquisition Circular. The associated NAICS code is 334516 (small business size standard: 1,000 employees); PSC 6640. This acquisition is unrestricted.
The U.S. Food and Drug Administration (FDA), National Forensic Chemistry Center (NFCC), Cincinnati, OH, requires three (3) new Rigaku IconX handheld 1064nm Raman spectrometers, including all standard features and accessories, CommandSuite software, familiarization training for up to six (6) users per instrument, and a three (3) year manufacturer's warranty, in accordance with the attached Statement of Work. Delivery is F.O.B. Destination to Cincinnati, OH 45237, no later than ninety (90) days after award.
This is a brand-name requirement pursuant to FAR 13.106-1(b); "or equal" products will not be evaluated. The Brand-Name Justification is posted with this notice in accordance with FAR 5.102(a)(6). Quotations will be accepted from the OEM or from dealers/resellers currently authorized by Rigaku Analytical Devices; quoters other than the OEM shall submit evidence of current authorization with their quotation.
The attached Combined Synopsis/Solicitation document constitutes the complete RFQ, including line items, instructions to quoters, and applicable provisions and clauses. Award will be made under FAR Part 13 Simplified Acquisition Procedures as a single firm-fixed-price purchase order to the responsible quoter whose quotation is the lowest priced and technically acceptable.
Quotations are due no later than 12:00 PM Eastern Time on July 29, 2026, by email to james.jenretteiii@fda.hhs.gov with subject line "RFQ OC-OCS-26-C-4920 - [Company Name]". Questions are due in writing by 12:00 PM Eastern Time on July 24, 2026. Quoters must have an active SAM.gov registration at the time of quotation submission and award.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Handheld X-Ray Fluorescence for ERDC GSL | Engineer Research and Development Center | No set-aside | |
| Sources Sought for (ICP-OES) Spectrometer System with an Autosampler | Naval Supply Systems Command | No set-aside | |
| CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap) | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity